Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible-dose lacosamide add-on therapy in partial-onset epilepsy
2010-019268-35Phase 4Completed
- Sponsor
- UCB
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lacosamide in epilepsy, sponsored by UCB. Primary endpoint: Adverse events (safety and tolerability). Started Mar 2010; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2010-019268-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019268-35.